Report Changes To WHO Prequalified IVDs Or Get Dropped From List, Guidance Says
This article was originally published in SRA
The World Health Organization has issued draft guidance on what changes relating to IVDs that fall under its prequalification program manufacturers must report to the WHO, what changes do not need reporting, and what changes might require a new application for prequalification1.
You may also be interested in...
A new fee structure for the prequalification of in vitro diagnostics by the World Health Organization is expected to come into effect in early 2018 following the introduction of a fee-for-service framework for medicines and vaccines in January 2017.
New medicines under evaluation at the European Medicines Agency.
The Pink Sheet’s list of EU centralized approvals of new active substances has been updated with seven new products including Roche's Polivy for treating diffuse large B-cell lymphoma. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).